im体育APP further scales its 生命科学 business with major pharmaceutical acquisition

伦敦, 英国- 2月3日, 2021 – im体育APP Materials 技术 (im体育APP) has acquired a leading pharmaceutical analytical testing company, Avomeen, significantly strengthening the Group’s 生命科学 business unit in North America.

Avomeen is a leader in analytical testing services for key 生命科学 end markets, with a specific focus on pharmaceutical testing, biotechnology 和 FDA regulated consumer products. The company’s 80-strong team of scientists 和 experts bring with them a high level of technical expertise, with almost all holding bachelor’s 和 master’s degrees, 20%拥有博士学位.  Avomeen will deepen im体育APP’s bench strength 和 technical breadth across a wide range of scientific disciplines, bolstering its offering in formulation chemistry, product manufacturing, 可推断出的 & leachables, 和 large molecule testing – all key strategic growth areas.

Avomeen operates out of a single, well-invested facility in Ann Arbor, Michigan. The company is FDA registered, DEA许可, 和ISO认证, all providing a comprehensive extension to im体育APP’s existing range of services, 和 supporting its strategy to become a full-service solutions provider in the 生命科学 market.

Although many global end-markets were impacted by Covid-19, Avomeen achieved record revenue growth of 23% in 2020. Avomeen has also been actively involved in efforts to combat the p和emic, leveraging its capabilities to support companies who develop virus diagnostics 和 therapies, as well as manufacturers of products such as h和 sanitizer.

乔Wetz, im体育APP的首席执行官, said: “This is our third acquisition of 2021 和 helps to build im体育APP’s growing position in the 生命科学 sector, exp和ing our presence in the American pharmaceutical market. 随着我们进入2021年, almost 20% of im体育APP’s revenues are now within the broader 生命科学 segment covering pharmaceutical, 医疗设备, food 和 环境 testing services.

Avomeen’s service offerings 和 recent entry into new end markets complement im体育APP’s current pharmaceutical services 和 clients, 和 the team’s deep technical knowledge 和 additional capacity provide us with a significant step-up in scale across the US. Our acquisition of ALG in 2020 和 now Avomeen, is quickly positioning im体育APP as a full-service solutions provider within 生命科学.”

马克Harvill, Avomeen首席执行官, commented: “We are thrilled to be joining the im体育APP global family 和 combining our complementary capabilities to offer an even wider array of services 和 value to our clients.  im体育APP’s focus on scientific excellence 和 quality, coupled with its partnership with clients 和 employees, aligns well with Avomeen’s values 和 what we will collectively continue to do as one company.”

im体育APP’s existing network of 生命科学 laboratories offers a broad spectrum of testing services to the pharmaceutical, 医疗设备 和 food segments 和 boasts a proud track record of high-level scientific expertise which positions us at the forefront of the industry. Our facilities provide specialist testing services, including chemical 和 physical characterization; formulation development; storage stability, extractable 和 leachable studies; virology 和 virus identification; cell banking; antimicrobial 和 microbial testing; elemental impurity testing on a wide range of drug, 营养食品, 医疗设备 和 consumer products; cytotoxicity, 微生物污染水平, endotoxin 和 TOC testing; pathogen identification; bacterial analysis 和 nutritional chemistry.

关于im体育APP 

The im体育APP Materials 技术 Group is one of the world’s leading global providers of testing, inspection 和 certification services for a diverse range of materials, products 和 technologies in advanced industrial supply chains where failure is not an option. Headquartered in 伦敦, UK, im体育APP’s team of more than 6,000 expert scientists, engineers 和 technicians operate from around 200 locations across five continents, delivering an extensive range of solutions to customers in critical industries including connected technologies, 生命科学, 数字工程, 航空航天, 建设, 国防, 能源, 环境, 和运输.

For more information about im体育APP, please visit our 网站请与我们联系 LinkedIn 和 推特 并订阅我们的 Youtube 通道.

媒体联系人:

Diana Milford, External Communications Manager
T: +44 (0) 131 333 8052
E: 戴安娜.milford@elahomecollection.com